# Treatment of Knee Osteoarthritis (KOA) by Injection of Autologous Adipose-derived Vascular Matrix Components (SVF) Into Joint Cavity

> **NCT06109220** · NA · UNKNOWN · sponsor: **Xijing Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Knee Osteoarthritis

## Interventions

- **BEHAVIORAL:** Stromal vascular fraction,SVF

## Key facts

- **NCT ID:** NCT06109220
- **Lead sponsor:** Xijing Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-03-30
- **Primary completion:** 2024-06-30
- **Final completion:** 2024-12-30
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2023-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06109220

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06109220, "Treatment of Knee Osteoarthritis (KOA) by Injection of Autologous Adipose-derived Vascular Matrix Components (SVF) Into Joint Cavity". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06109220. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*